T2	Participants 109 121	240 patients
T3	Participants 26 63	tranexamic acid in knee arthroplasty:
T1	Participants 497 543	(four intravenous, one local; 40 patients each
T4	Participants 592 877	four intravenous (10-mg/kg dose) regimens included (1) intraoperative dose (IO) given before tourniquet deflation, (2) additional preoperative dose (POIO), (3) additional postoperative dose (IOPO), and (4) all three doses (POIOPO). The fifth regimen was a single local application (LA)
